Gemtuzumab Ozogamicin

Category: Cancer

Gemtuzumab Ozogamicin Overview

Gemtuzumab ozogamicin, sold under the brand name Mylotarg, is an antibody-drug conjugate (a drug-linked monoclonal antibody) that is used to treat acute myeloid leukemia.[2] The most common grade 3 and higher adverse reactions that occurred during Induction 1 and Intensification 2 in ≥ 5% of people who received gemtuzumab ozogamicin were infection, febrile neutropenia, decreased appetite, hyperglycemia, mucositis, hypoxia, hemorrhage, increased transaminase, diarrhea, na...

Read more Gemtuzumab Ozogamicin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gemtuzumab_ozogamicin

Recent Gemtuzumab Ozogamicin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Gemtuzumab Ozogamicin or a similar ingredient: (1 result)

• MYLOTARG Gemtuzumab Ozogamicin2 discussions